Abstract
Social phobia is the third most common psychiatric illness in the community. It is characterised by a marked and persistent fear of one or more social or performance situations in which the individual is exposed to unfamiliar people or to possible scrutiny by others. Social phobia is often associated with significant morbidity and functional impairment. Treatments for social phobia have started to be extensively evaluated over the past decade and there is now evidence for the effectiveness of cognitive behavioural therapy and pharmacotherapy. Controlled studies support the efficacy of nonselective monoamine oxidase inhibitors (MAOIs), reversible inhibitors of monoamine oxidase-A (RIMAs), high potency benzodiazepines and, most recently, selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitors (SSRIs).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
